Elisigen, Inc.
Overview
Elisigen develops AAV-based gene therapies designed to address the root causes of disease.
Therapeutic areas
Cell & Gene TherapyRare Diseases
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Elisigen, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.